Marathon Capital Management Adma Biologics, Inc. Transaction History
Marathon Capital Management
- $414 Million
- Q3 2025
A detailed history of Marathon Capital Management transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Marathon Capital Management holds 466,570 shares of ADMA stock, worth $7.26 Million. This represents 1.65% of its overall portfolio holdings.
Number of Shares
466,570
Previous 283,690
64.46%
Holding current value
$7.26 Million
Previous $5.17 Million
32.41%
% of portfolio
1.65%
Previous 1.37%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
400Shares Held
205MCall Options Held
3.06MPut Options Held
1.88M-
Vanguard Group Inc Valley Forge, PA21MShares$326 Million0.0% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$290 Million0.0% of portfolio
-
State Street Corp Boston, MA13.6MShares$211 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.5MShares$195 Million0.03% of portfolio
-
Sachem Head Capital Management LP New York, NY8.96MShares$139 Million5.63% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.06B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...